Siemens seeks shareholders nod to hive off healthcare arm

Published On 2016-03-23 05:24 GMT   |   Update On 2016-03-23 05:24 GMT
New Delhi: German conglomerate Siemens sought shareholders' approval on the proposed sale and transfer of its healthcare undertaking in the country to its subsidiary Siemens Healthcare for a consideration of Rs 3,050 crore.

"Siemens Ltd proposes to sell and transfer its Healthcare Undertaking as a 'going concern' and by way of a slump sale to Siemens Healthcare Pvt Ltd, a subsidiary of Siemens Aktiengesellschaft, Germany with effect from July 1, 2016 for a lump sum consideration of Rs 3,050 crore," the company said in a postal ballot notice to shareholders.

"Accordingly, the proposed ordinary resolution and the statement setting out material facts thereof are being sent to you along with a Postal Ballot Form for your consideration," it added.

The transaction will enable Siemens to increase its focus on, and capital allocation to power generation, transmission and distribution, mobility, industrial automation and smart cities segments in the country, Siemens India Managing Director and CEO Sunil Mathur has earlier said in a note.

He said the deal enables Siemens AG to further strengthen its focus on the healthcare segment here by aligning it with its global strategy and management framework.

The proposed transaction, recommended by the audit committee, is based on the valuation undertaken by two independent valuers Deloitte Touche Tohmatsu India and KPMG India.
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News